DLHIX vs. FBTCX

Last updated Jun 4, 2026

DLHIX (Delaware Healthcare Fund) and FBTCX (Fidelity Advisor Biotechnology Fund Class C) are both Health & Biotech Equities funds. Over the past 10 years, DLHIX returned 10.09%/yr vs 8.99%/yr for FBTCX. Their correlation of 0.82 suggests significant overlap in exposure. DLHIX charges 0.98%/yr vs 1.75%/yr for FBTCX.

Performance

DLHIX vs. FBTCX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Delaware Healthcare Fund (DLHIX) and Fidelity Advisor Biotechnology Fund Class C (FBTCX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, DLHIX achieves a -4.36% return, which is significantly lower than FBTCX's -1.15% return. Over the past 10 years, DLHIX has outperformed FBTCX with an annualized return of 10.09%, while FBTCX has yielded a comparatively lower 8.99% annualized return.

DLHIX

• 1D: -2.28%
• 1M: -2.21%
• YTD: -4.36%
• 6M: -4.03%
• 1Y: 21.49%
• 3Y*: 11.04%
• 5Y*: 6.91%
• 10Y*: 10.09%

FBTCX

• 1D: -3.07%
• 1M: -5.65%
• YTD: -1.15%
• 6M: -4.56%
• 1Y: 43.21%
• 3Y*: 13.61%
• 5Y*: 7.05%
• 10Y*: 8.99%

*Multi-year figures are annualized to reflect compound growth (CAGR)

DLHIX vs. FBTCX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
DLHIX Delaware Healthcare Fund	-4.36%	22.27%	8.76%	5.42%	-0.99%	5.48%	12.02%	31.82%	-0.59%	32.29%
FBTCX Fidelity Advisor Biotechnology Fund Class C	-1.15%	38.48%	-2.00%	9.86%	-8.64%	-3.72%	31.17%	24.82%	-4.55%	24.81%

Correlation

The correlation between DLHIX and FBTCX is 0.80, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.80
Correlation (3Y) Calculated over the trailing 3-year period	0.81
Correlation (5Y) Calculated over the trailing 5-year period	0.83
Correlation (10Y) Calculated over the trailing 10-year period	0.84
Correlation (All Time) Calculated using the full available price history since Oct 1, 2007	0.82

The correlation between DLHIX and FBTCX has been stable across timeframes, ranging from 0.80 to 0.84 - a consistent structural relationship.

Return for Risk

DLHIX vs. FBTCX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DLHIX

DLHIX Risk / Return Rank: 23
DLHIX Sharpe Ratio Rank: 20
DLHIX Sortino Ratio Rank: 21
DLHIX Omega Ratio Rank: 18
DLHIX Calmar Ratio Rank: 30
DLHIX Martin Ratio Rank: 25

FBTCX

FBTCX Risk / Return Rank: 60
FBTCX Sharpe Ratio Rank: 48
FBTCX Sortino Ratio Rank: 45
FBTCX Omega Ratio Rank: 40
FBTCX Calmar Ratio Rank: 92
FBTCX Martin Ratio Rank: 77

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DLHIX vs. FBTCX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Delaware Healthcare Fund (DLHIX) and Fidelity Advisor Biotechnology Fund Class C (FBTCX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	DLHIX	FBTCX	Difference
Sharpe ratio: Return per unit of total volatility	1.29	2.04	-0.75
Sortino ratio: Return per unit of downside risk	1.92	2.81	-0.89
Omega ratio: Gain probability vs. loss probability	1.22	1.33	-0.11
Calmar ratio: Return relative to maximum drawdown	2.06	4.97	-2.91
Martin ratio: Return relative to average drawdown	6.24	14.52	-8.29
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

DLHIX vs. FBTCX - Sharpe Ratio Comparison

The current DLHIX Sharpe Ratio is 1.29, which is lower than the FBTCX Sharpe Ratio of 2.04. The chart below compares the historical Sharpe Ratios of DLHIX and FBTCX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	DLHIX	FBTCX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.29	2.04	-0.75
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.44	0.30	+0.14
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.56	0.37	+0.20
Sharpe Ratio (All Time) Calculated using the full available price history	0.70	0.26	+0.44

Drawdowns

DLHIX vs. FBTCX - Drawdown Comparison

The maximum DLHIX drawdown since its inception was -34.64%, smaller than the maximum FBTCX drawdown of -64.04%. Use the drawdown chart below to compare losses from any high point for DLHIX and FBTCX.

Drawdown Indicators

	DLHIX	FBTCX	Difference
Max Drawdown Largest peak-to-trough decline	-34.64%	-64.04%	+29.40%
Max Drawdown (1Y) Largest decline over 1 year	-10.30%	-9.04%	-1.26%
Max Drawdown (3Y) Largest decline over 3 years	-19.79%	-37.26%	+17.47%
Max Drawdown (5Y) Largest decline over 5 years	-19.79%	-37.26%	+17.47%
Max Drawdown (10Y) Largest decline over 10 years	-25.60%	-39.37%	+13.77%
Current Drawdown Current decline from peak	-7.85%	-9.04%	+1.19%
Average Drawdown Average peak-to-trough decline	-5.56%	-23.08%	+17.52%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.39%	3.09%	+0.30%

Volatility

DLHIX vs. FBTCX - Volatility Comparison

The current volatility for Delaware Healthcare Fund (DLHIX) is 4.73%, while Fidelity Advisor Biotechnology Fund Class C (FBTCX) has a volatility of 7.10%. This indicates that DLHIX experiences smaller price fluctuations and is considered to be less risky than FBTCX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	DLHIX	FBTCX	Difference
Volatility (1M) Calculated over the trailing 1-month period	4.73%	7.10%	-2.37%
Volatility (6M) Calculated over the trailing 6-month period	11.97%	16.73%	-4.76%
Volatility (1Y) Calculated over the trailing 1-year period	16.50%	22.12%	-5.62%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	15.96%	23.63%	-7.67%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	17.93%	24.49%	-6.56%

DLHIX vs. FBTCX - Expense Ratio Comparison

DLHIX has a 0.98% expense ratio, which is lower than FBTCX's 1.75% expense ratio.

Dividends

DLHIX vs. FBTCX - Dividend Comparison

DLHIX's dividend yield for the trailing twelve months is around 11.66%, more than FBTCX's 1.70% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
DLHIX Delaware Healthcare Fund	11.66%	11.16%	14.00%	6.97%	9.16%	5.41%	6.19%	7.63%	2.11%	3.23%	8.20%	7.90%
FBTCX Fidelity Advisor Biotechnology Fund Class C	1.70%	1.68%	0.00%	0.00%	0.00%	24.50%	9.78%	7.92%	2.92%	0.00%	0.00%	5.73%

Frequently Asked Questions

Can I hold both DLHIX and FBTCX in my portfolio?

DLHIX and FBTCX have a correlation of 0.80, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, DLHIX or FBTCX?

FBTCX has higher volatility (7.10%) compared to DLHIX (4.73%). In terms of maximum drawdown, DLHIX dropped -34.64% vs FBTCX's -64.04%.

Which has better risk-adjusted returns?

FBTCX currently has the higher Sharpe Ratio (2.04 vs 1.29), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.